Literature DB >> 7926793

A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA--promoter DNA complex formation.

P M Lieberman1, A J Berk.   

Abstract

TATA-binding protein (TBP)-associated factors (TAFs) in TFIID are required for activator proteins to stimulate transcription, but the mechanism by which TAFs function is poorly understood. To study how TAFs participate in transcriptional activation by the Epstein-Barr virus activator Zta, we used agarose gel electrophoresis and DNase I footprinting to compare transcription complex assembly in reactions with either TFIID or TBP in the presence and absence of wild-type Zta or a deletion of Zta lacking its activation domain. A stable complex of promoter DNA with Zta, TFIIA, and TFIID rapidly formed on a template with Zta-binding sites. Zta stimulation of stable complex formation required TAFs as well as the Zta activation domain and TFIIA. The Zta activation domain also induced a TAF-dependent DNA-protein interaction near and downstream of the transcription star site. Stable complexes formed within 1 min supported activated transcription when RNA polymerase II and the remaining general transcription factors were subsequently added. This rapid assembly of a stable Zta-TFIIA-TFIID-promoter complex is probably a significant component of the mechanism by which TAFs and the Zta activation domain cooperate to stimulate transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926793     DOI: 10.1101/gad.8.9.995

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  109 in total

1.  Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly.

Authors:  K Ellwood; W Huang; R Johnson; M Carey
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.

Authors:  D Zerby; C J Chen; E Poon; D Lee; R Shiekhattar; P M Lieberman
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  p53 Stimulates TFIID-TFIIA-promoter complex assembly, and p53-T antigen complex inhibits TATA binding protein-TATA interaction.

Authors:  J Xing; H M Sheppard; S I Corneillie; X Liu
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Distinct cAMP response element-binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.

Authors:  J Kim; J Lu; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA.

Authors:  Kristina M Johnson; Jin Wang; Andrea Smallwood; Charina Arayata; Michael Carey
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

Review 6.  Multi-protein complexes in eukaryotic gene transcription.

Authors:  Ernest Martinez
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

7.  Positive and negative functions of the SAGA complex mediated through interaction of Spt8 with TBP and the N-terminal domain of TFIIA.

Authors:  Linda Warfield; Jeffrey A Ranish; Steven Hahn
Journal:  Genes Dev       Date:  2004-05-01       Impact factor: 11.361

8.  Differential cellular requirements for activation of herpes simplex virus type 1 early (tk) and late (gC) promoters by ICP4.

Authors:  Susan Zabierowski; Neal A DeLuca
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  TFIIB-facilitated recruitment of preinitiation complexes by a TAF-independent mechanism.

Authors:  Roderick T Hori; Shuping Xu; Xianyuan Hu; Sung Pyo
Journal:  Nucleic Acids Res       Date:  2004-07-22       Impact factor: 16.971

10.  The activation domain of GAL4 protein mediates cooperative promoter binding with general transcription factors in vivo.

Authors:  S Vashee; T Kodadek
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.